Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Lassus

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Intensive Care Medicine|February 9, 2019
Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock StudyAlessandro Sionis, Mercedes Rivas-Lasarte, Alexandre Mebazaa, et al.
Intensive Care Medicine|May 17, 2018
Management of cardiogenic shock complicating myocardial infarctionAlexandre Mebazaa, Alain Combes, Sean van Diepen, et al.
ESC Heart Failure|February 1, 2021
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock studyMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of the American College of Cardiology|July 7, 2018
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial InfarctionBruno Levy, Raphael Clere-Jehl, Annick Legras, et al.
International Journal of Cardiology|August 26, 2020
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock studyAnu Kataja, Tuukka Tarvasmäki, Johan Lassus, et al.
Annals of Intensive Care|January 5, 2017
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shockHeli Tolppanen, Mercedes Rivas-Lasarte, Johan Lassus, et al.
European Heart Journal. Acute Cardiovascular Care|February 1, 2020
External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patientsMercedes Rivas-Lasarte, Jordi Sans-Roselló, Elena Collado-Lledó, et al.
European Journal of Heart Failure|January 8, 2020
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of CardiologyWilfried Mullens, Kevin Damman, Jeffrey M Testani, et al.
Journal of the American College of Cardiology|December 10, 2013
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradoxRavi Shah, Etienne Gayat, James L Januzzi, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Intensive Care Medicine|February 9, 2019
Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock StudyAlessandro Sionis, Mercedes Rivas-Lasarte, Alexandre Mebazaa, et al.
Intensive Care Medicine|May 17, 2018
Management of cardiogenic shock complicating myocardial infarctionAlexandre Mebazaa, Alain Combes, Sean van Diepen, et al.
ESC Heart Failure|February 1, 2021
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock studyMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of the American College of Cardiology|July 7, 2018
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial InfarctionBruno Levy, Raphael Clere-Jehl, Annick Legras, et al.
International Journal of Cardiology|August 26, 2020
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock studyAnu Kataja, Tuukka Tarvasmäki, Johan Lassus, et al.
Annals of Intensive Care|January 5, 2017
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shockHeli Tolppanen, Mercedes Rivas-Lasarte, Johan Lassus, et al.
European Heart Journal. Acute Cardiovascular Care|February 1, 2020
External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patientsMercedes Rivas-Lasarte, Jordi Sans-Roselló, Elena Collado-Lledó, et al.
European Journal of Heart Failure|January 8, 2020
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of CardiologyWilfried Mullens, Kevin Damman, Jeffrey M Testani, et al.
Journal of the American College of Cardiology|December 10, 2013
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradoxRavi Shah, Etienne Gayat, James L Januzzi, et al.
Pageof 9